Journal of Family Medicine and Primary Care

EDITORIAL
Year
: 2020  |  Volume : 9  |  Issue : 5  |  Page : 2149--2157

Preventive and treatment strategies of COVID-19: From community to clinical trials


Kamal Kant Sahu1, Raman Kumar2 
1 Department of Internal Medicine, Saint Vincent Hospital, Massachusetts, United States of America
2 President Academy of Family Physicians of India, New Delhi, India

Correspondence Address:
Dr. Kamal Kant Sahu
Department of Internal Medicine, Saint Vincent Hospital, 123 Summer Street Worcester, Massachusetts - 01608
United States of America

The latest threat to global health is the form of the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. This new coronavirus (SARS-COV-2) started as a local outbreak in Wuhan, China but soon tightened its grip on human lives around the globe. So far, we do not have a particularly effective anti-SARS-COV-2 vaccine or antiviral agent against COVID-19. Across the globe, many research organizations such as the National Institutes of Health (NIH), United States are studying and testing various drugs and vaccines for their effectiveness against SARS-COV-2. Currently, the principle fighting tool being promoted by the World Health Organization (WHO) is the prevention of acquiring SARS-COV-2 infection by following basic health hygiene rules and social distancing. We hereby discuss major non-pharmacological and pharmacological interventions.


How to cite this article:
Sahu KK, Kumar R. Preventive and treatment strategies of COVID-19: From community to clinical trials.J Family Med Prim Care 2020;9:2149-2157


How to cite this URL:
Sahu KK, Kumar R. Preventive and treatment strategies of COVID-19: From community to clinical trials. J Family Med Prim Care [serial online] 2020 [cited 2020 Jul 15 ];9:2149-2157
Available from: http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=5;spage=2149;epage=2157;aulast=Sahu;type=0